Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001181431-05-041014

President and CEO acquired 80,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DRISCOLL FREDERICK W · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2005-07-15 Grant or award : show line 1 in the form +80,000 122,000 D
Loading xslF345X02/rrd85651.xml…